TITLE

Bone marrow potential

AUTHOR(S)
Choi, Stephen
PUB. DATE
February 2004
SOURCE
CMAJ: Canadian Medical Association Journal;2/3/2004, Vol. 170 Issue 3, p331
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents research updates on bone stem cells and platelets as of February 2004. Potential of bone marrow cells as alternative to stem cells in pluripotentiality; Technique discovered that could prolong the shelf life of blood platelets.
ACCESSION #
12017422

Tags: BLOOD platelets;  STEM cells;  BONE marrow cells;  IMMUNE system;  MEDICINE -- Research

 

Related Articles

  • Immunology: Blood lines redrawn. Graf, Thomas // Nature;4/10/2008, Vol. 452 Issue 7188, p702 

    The article focuses on the central aspect of blood-cell differentiation. The main components of the blood are red cells, whites cells and platelets. These were produced from the haematopoietic stem cells as a common source. On the other hand, the white cells or the leukocytes functions as an...

  • Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction -- a cardiovascular magnetic resonance tagging study. Hopp, Einar; Lunde, Ketil; Solheim, Svein; Aakhus, Svend; Arnesen, Harald; Forfang, Kolbj�rn; Edvardsen, Thor; Smith, Hans-J�rgen // Journal of Cardiovascular Magnetic Resonance (BioMed Central);2011, Vol. 13 Issue 1, p22 

    Background: Trials have brought diverse results of bone marrow stem cell treatment in necrotic myocardium. This substudy from the Autologous Stem Cell Transplantation in Acute Myocardial Infarction trial (ASTAMI) explored global and regional myocardial function after intracoronary injection of...

  • Essential Thrombocythemia. Sanchez, Steven; Ewton, April // Archives of Pathology & Laboratory Medicine;Aug2006, Vol. 130 Issue 8, p1144 

    Context.�Essential thrombocythemia (ET) is a chronic myeloproliferative disorder (CMPD) characterized predominately by thrombocytosis and abnormal megakaryocyte proliferation. The current diagnostic criteria require a combination of clinical, histologic, and cytogenetic data. The diagnosis...

  • Reconstitution of the myeloid and lymphoid compartments after the transplantation of autologous and genetically modified CD34+ bone marrow cells, following gamma irradiation in cynomolgus macaques. Derdouch, Sonia; Gay, Wilfried; N�gre, Didier; Prost, St�phane; Le Dantec, Mikael; Delache, Beno�t; Auregan, Gwenaelle; Andrieu, Thibault; Leplat, Jean-Jacques; Cosset, Fran�ois-Lo�c; Le Grand, Roger // Retrovirology;2008, Vol. 5, Special section p1 

    Background: Prolonged, altered hematopoietic reconstitution is commonly observed in patients undergoing myeloablative conditioning and bone marrow and/or mobilized peripheral blood-derived stem cell transplantation. We studied the reconstitution of myeloid and lymphoid compartments after the...

  • Comment on CD34+ selected hematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment of graft failure. Lang, P.; Niethammer, D.; Bader, P.; Greil, J. // Bone Marrow Transplantation;Mar2005, Vol. 35 Issue 5, p522 

    This article presents a response to the study, conducted by scientist G. Milone and colleagues, which states that selected hematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy is an effective treatment of graft failure. The scientists refer to a case of a 12-year-old boy...

  • AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1. Takeshita, M.; Ichikawa, M.; Nitta, E.; Goyama, S.; Asai, T.; Ogawa, S.; Chiba, S.; Kurokawa, M. // Leukemia (08876924);Jun2008, Vol. 22 Issue 6, p1241 

    The t(3;21) chromosomal translocation seen in blastic crisis of chronic myeloid leukemia and secondary leukemias results in a formation of a chimeric protein AML1-Evi-1, which suppresses wild-type AML1 function. Loss of AML1 function causes expansion of hematopoietic progenitor cells, whereas it...

  • Hematopoietic Stem Cells (HSC). Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p280 

    A definition of the term "hematopoietic stem cells" (HSC) is presented. It refers to a population of self-renewing cells committed to blood cell formation. Stem cells have the capacity to repopulate the blood forming and immune systems in irradiated hosts. HSC differentiate and generate...

  • Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Ott, Marion G.; Schmidt, Manfred; Schwarzwaelder, Kerstin; Stein, Stefan; Siler, Ulrich; Koehl, Ulrike; Glimm, Hanno; K�hlcke, Klaus; Schilz, Andrea; Kunkel, Hana; Naundorf, Sonja; Brinkmann, Andrea; Deichmann, Annette; Fischer, Marlene; Ball, Claudia; Pilz, Ingo; Dunbar, Cynthia; Yang Du; Jenkins, Nancy A.; Copeland, Neal G. // Nature Medicine;Apr2006, Vol. 12 Issue 4, p401 

    Gene transfer into hematopoietic stem cells has been used successfully for correcting lymphoid but not myeloid immunodeficiencies. Here we report on two adults who received gene therapy after nonmyeloablative bone marrow conditioning for the treatment of X-linked chronic granulomatous disease...

  • Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Walkley, Carl R.; Fero, Matthew L.; Chien, Wei-Ming; Purton, Louise E.; McArthur, Grant A. // Nature Cell Biology;Feb2005, Vol. 7 Issue 2, p172 

    Haematopoietic stem cells (HSCs) are capable of shifting from a state of relative quiescence under homeostatic conditions to rapid proliferation under conditions of stress. The mechanisms that regulate the relative quiescence of stem cells and its association with self-renewal are unclear, as is...

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics